International Flavors & Fragrances (IFF) Consumer Analyst Group of New York Conference (CAGNY) 2026 summary
Event summary combining transcript, slides, and related documents.
Consumer Analyst Group of New York Conference (CAGNY) 2026 summary
19 Feb, 2026Strategic transformation, financial discipline, and business model
Executed portfolio optimization with 11 divestitures, generating over $6B in gross proceeds and improving capital structure, reducing leverage from 4.5x to 2.6x net debt/EBITDA by 2025.
Adopted a business unit-led operating model, enhanced leadership and employee engagement, and evolved the Board of Directors.
Reinvested $150 million in OpEx from 2024–2026 and increased CapEx to support innovation, R&D, commercial capabilities, capacity expansion, and digital transformation, targeting 4–6% of sales through 2026.
Launched a $500 million share buyback program, the first in six years, to offset dilution and capture intrinsic value.
Focused on high-return investments, productivity, and capital allocation to higher-margin categories, driving disciplined execution and cash conversion.
Financial performance and guidance
Projected average comparable currency neutral sales growth of 4% and adjusted EBITDA growth of 10% between 2024 and 2026, driven by core divisions.
Food Ingredients expected to deliver 500 bps of EBITDA margin expansion over three years.
Core businesses targeting mid-single-digit sales and high-single-digit EBITDA growth CAGRs over time.
Portfolio and market positioning
Shifted toward higher-value, higher-growth, and higher-margin businesses, increasing average gross profit margin from 29% (divested) to 36%.
Maintains a diversified portfolio across Taste, Scent, Health & Biosciences, and Food Ingredients, serving approximately 20,000 customers globally.
Strong presence in both developed (54%) and emerging (47%) markets.
Latest events from International Flavors & Fragrances
- Disciplined execution, portfolio focus, and strong governance drove 2025 progress and value creation.IFF
Proxy Filing18 Mar 2026 - Shareholders can vote on annual meeting proposals online or virtually by April 28, 2026.IFF
Proxy Filing18 Mar 2026 - Adjusted EBITDA rose 7% on 2% currency-neutral sales growth, with major divestitures and $1.15B goodwill impairment.IFF
Q4 202512 Feb 2026 - Adjusted EBITDA up 22% and full-year guidance raised on strong volume and margin gains.IFF
Q2 20242 Feb 2026 - Strategy centers on innovation, targeted investment, and business unit empowerment for sustained growth.IFF
Barclays 17th Annual Global Consumer Staples Conference22 Jan 2026 - Strong Q3 growth and raised 2024 outlook driven by volume recovery and margin gains.IFF
Q3 202416 Jan 2026 - Strong 2024 growth and margin gains; 2025 outlook tempered by FX and divestitures.IFF
Q4 20248 Jan 2026 - Biotech innovation and disciplined strategy drive strong results and future growth potential.IFF
Consumer Analyst Group of New York Conference 20257 Jan 2026 - Directors elected, auditor ratified, and executive pay approved; CEO pay structure discussed.IFF
AGM 202525 Dec 2025